Loading data for BAX — first visit, this takes a few seconds.

Preisalarm

Baxter International Inc. (BAX)

NYSE: BAX · Echtzeitkurs · USD

25.94

+0.03 (0.12%)

Zum Schluss: Aug 18, 2026, 8:00 PM

0.12% (1D)

Keine Daten verfügbar

Geld	25.85
Marktkapitalisierung	13.41 Mrd
Umsatz (TTM)	11.47 Mrd
Nettogewinn (TTM)	-968 Mio
Beta	0.59
EPS (ttm)	-1.88
KGV (TTM)	n/a
Forward-KGV	12.74
KBV (TTM)	2.16
KUV (TTM)	1.17
Earnings Date	Oct 29, 2026

Brief	26.89
Volumen	6,671,572
Ø Vol. (20D)	7,031,929
Eröffnung	26.08
Vortagesschluss	25.91
Tagesspanne	25.75 - 26.34
52-Wk Range	15.73 - 30.00
Analyst	n/a
Kursziel	n/a
Dividenden	$0.04 (0.15%)
Ex-Dividenden-Datum	28. Aug. 2026

Über BAX

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant produ...

[Mehr lesen]

Branche Medical Instruments & Supplies

Sektor Healthcare

IPO Datum Oct 27, 1981

Mitarbeiter 37,500

Börse NYSE

Tickersymbol BAX

Website https://www.baxter.com

Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr 2025 betrug der Umsatz von Baxter International 11.24 Mrd, ein Anstieg von 5.72% im Vergleich zum Vorjahr (10.64 Mrd). Der Gewinn lag bei -957 Mio, ein Anstieg von 47.46 %.

Finanzberichte

Gewinnüberraschung

Baxter International hat die Quartalszahlen am Jul 30, 2026 veröffentlicht:

Umsatz von $2.96 Mrd verfehlt die Erwartungen um $0, mit 5.34% Wachstum im Jahresvergleich.

EPS von 0.56 übertrifft die Erwartungen um 0.19, mit -5.08% Rückgang im Jahresvergleich.

Nächste Ergebnisveröffentlichung

Baxter International Inc. wird voraussichtlich die Quartalszahlen veröffentlichen am Oct 29, 2026, vor Börseneröffnung.
Analysten erwarten einen Umsatz von ... Upgrade

Nachrichten

vor 2 Tagen · StockStory

3 Stocks Under $50 with Questionable Fundamentals

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune t...

vor 4 Tagen · Zacks

WST Stock Surges 38.1% Since March-End: What's Fueling the Rally?

West Pharmaceutical Services has surged 38.1% since March-end as HVP demand, GLP-1 growth and productivity gains fuel the rally.

vor 5 Tagen · Zacks

Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins

OMCL raised its 2026 EPS outlook after a strong second quarter, but rising memory-chip costs and delayed hospital purchases could test margins.

vor 1 Woche · Simply Wall St.

Does Cardinal Health’s New CAO and Recalls Reveal Shifts in Its Risk Profile and Earnings Quality (CAH)?

In early August 2026, Cardinal Health announced that Anita Zielinski will become Chief Accounting Officer in November, following her interim CFO and senior accounting roles at Baxter and long tenure a...

vor 2 Wochen · Simply Wall St.

Baxter (BAX) Stock Gets Fair Value Boost After Q2 Beat And Higher Targets

Baxter International is back in focus after the fair value estimate in one widely used model moved from US$21.54 to US$27.29, a change of about 27% that feeds directly into updated price target discus...

Seite 1 von 2

Baxter International Inc. (BAX)